
Mometasone: A mid-strength prescription steroid applied once a day for eczema, psoriasis and other itchy rashes. Strong enough to settle a flare, measured enough for short courses on most of the body. Skyrizi: An injected biologic for moderate to severe plaque psoriasis. It blocks interleukin-23, a signal that sits high up in the psoriasis chain, and after two starting doses it is given about four times a year.


Choose to settle an eczema or psoriasis flare on the body with a once-daily, mid-strength steroid.
Choose for moderate to severe psoriasis when you want high clearance with only about four injections a year.
Can you take them together?
Mometasone is often used on remaining patches while on Skyrizi. It does not interact with the biologic.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.











Activates steroid receptors: Binds receptors inside skin and immune cells. Turns down inflammatory signals: Changes gene activity to reduce inflammatory messengers. Eases redness and itch: Swelling and irritation settle as inflammation falls.
Simplified glucocorticoid receptor-mediated effects in steroid-responsive skin inflammation. Full effects also involve other pathways. No claim of antimicrobial action or cure; formulation and potency affect clinical use.

Blocks IL-23: Binds this immune messenger before it reaches its receptor. Turns down inflammatory T cells: Reduces signals that keep the psoriasis cycle active. Helps plaques clear: Excess skin buildup and inflammation gradually decrease.
Risankizumab selectively targets the p19 subunit of IL-23, not IL-12. The T-cell and skin changes are a simplified downstream interpretation.
When to Apply: Once a day, a thin film on the rash only, not the skin around it. A fingertip length covers roughly two flat palms. Moisturizer can go on the same skin at other times.
How to Start: Once daily from day one until the skin is smooth and not itchy, usually a few days to two weeks. Under-using it is the commoner mistake. Then stop, or step down to twice a week if your doctor set that up.
If It Irritates: A short sting on cracked or raw skin is common and settles as the skin heals. Moisturizing twenty minutes before or after helps. Burning that worsens over days can mean infection, a reaction to the base, or the wrong diagnosis.
If It’s Not Working: Two weeks of daily use with no change means something else is going on — too little applied, a fungal or infected rash that steroids make worse, or a rash needing a stronger cream or a different drug. Do not keep going past that without a review.
Two starting doses close together, then a long steady interval. Not adjusted for body weight.
Starting dose: 150 mg as one injection.
Second dose: 150 mg, four weeks after the first.
Usual dose: 150 mg every 12 weeks — about four injections a year after the first year.
If it stops working: There is no approved higher dose or shorter interval for psoriasis. Losing response means reviewing the diagnosis, not injecting more often.
How long: Long term, with no set end point, while it works and is tolerated.
No blood tests for ordinary use. Monitoring is looking at the skin: is the treated area thinner or shinier than the skin beside it, are small veins showing, are there stretch marks in the folds or pus bumps around hair follicles.
The exception is large-area, long-term or covered use, and use in small children, where enough can be absorbed to affect the body’s own steroid production. Uncommon, and why a doctor sets an area and a time limit.
The checkpoint is a review at two to four weeks. Using it most weeks over months means the question is no longer the cream but what long-term treatment should be doing this job.
Everyone is screened for tuberculosis before the first dose — a skin test or TB blood test, plus a chest X-ray if that is positive. Dormant TB is treated first. This class probably carries less TB risk than the TNF blockers, but screening is not optional.
Hepatitis B and C are usually checked at the same time.
After that there is no fixed blood test schedule. Risankizumab does not need the regular liver and blood count testing methotrexate does. Monitoring is clinical: the skin, whether infections are more frequent, whether the dose dates are kept. TB testing is repeated yearly or by exposure risk.
There is no boxed warning. The most common side effects reported are upper respiratory infections, headache, tiredness, fungal skin infections and injection site reactions. Serious allergic reactions are rare but are why the first dose is often given with someone trained nearby.
Any time of day. The calendar matters more here than with a weekly drug. Twelve weeks is long enough that people lose track, so put every dose date in your phone and book the next reminder the day you inject.
Take it out of the fridge 15 to 30 minutes before and let it warm on the counter. Cold liquid stings. No hot water, no microwave.
Inject into the front of the thigh or the belly, at least two inches from the navel. The back of the upper arm works if someone else is doing it. Rotate the site, avoid skin that is bruised, tender, hard or scarred, and never inject through a plaque. Ask for training before the first dose. Used devices go in a sharps container.
Inject as soon as you remember, then count twelve weeks from that day. If it has been much longer than twelve weeks, call the prescriber first so the schedule can be reset.
Approximate windows, not promises.
First few minutesApplying it: A thin layer once a day, on the affected skin only.
First few minutesThe injection: A sharp sting for a few seconds, then redness or a small welt. Settles within a day or two.
Days 1 to 3Itch first: Itch eases before the rash looks different. Normal, and not a reason to add more.
Days 3 to 14Working: Redness fades, scale flattens, weeping stops. Most short courses finish here, and moisturizer keeps going after the steroid stops.
Weeks 2 to 4Judge it here: If it is clear, stop or move to twice-weekly maintenance.
Weeks 2 to 6Psoriasis plaques: Scale lifts and plaques flatten. Something else usually runs alongside, since steroids rarely hold psoriasis on their own.
Weeks to monthsThickened, leathery patches: Skin rubbed and scratched for a long time takes longest, because the thickening itself has to reverse.
Beyond a few weeks of continuous useThe risks: Thinning skin, visible small veins, stretch marks in folds, small pus bumps around hair follicles. Uncommon on short courses, and why long courses are planned rather than drifted into.
Weeks 1 to 4Starting: Itch settles first. Scale lifts and plaques thin.
Weeks 4 to 16Working: Most of the change happens here, from the second dose on. Plaques flatten and redness fades from the middle out, often leaving a paler or darker mark.
Week 16Judge it here: Most people reached 90 percent clearer skin, and many were clear or nearly clear. Joints improve on the same timeline.
3 to 6 monthsScalp, palms and soles: Slower than the trunk and limbs.
6 to 12 monthsNails: Last to change, because a nail takes months to grow out.
Between dosesSteady state: Most people notice no dip. If plaques reliably return in the last few weeks, say so.
Sorted by what to do about them.
Generic mometasone is inexpensive and widely stocked, and the cream and ointment are on most low-cost generic lists. The Elocon brand costs considerably more for the same molecule.
The lotion and scalp solution usually cost more, and are sometimes the versions a plan will not cover. If cost is the issue, ask whether a different base at the same 0.1% would do the job.
The list price runs to tens of thousands of dollars a year. Almost nobody pays that; what you pay depends on your plan.
It is brand only — no generic, no biosimilar — so there is no cheaper equivalent to switch to. That is a real difference from adalimumab.
Prior authorization is close to universal. Most plans require documented failure of something cheaper first — phototherapy, methotrexate, sometimes another biologic. Denials are usually about missing records rather than the drug, and appeals succeed reasonably often when the history is documented.
Manufacturer copay cards can cut the cost to very little with commercial insurance. By law they cannot be used with Medicare or Medicaid. For those plans, or no insurance, the manufacturer's patient assistance program and independent foundations are the usual routes. Terms change often.
One practical note: because doses are twelve weeks apart, a change of insurance or a formulary switch in January can land in the middle of a dosing gap. Check coverage before the next dose is due, not the week it is.
Two to four weeks on a defined area. Longer should be your doctor's decision, usually as twice-weekly maintenance.
Only if your doctor said so, and briefly. Facial skin absorbs far more and shows thinning first. Milder or non-steroid creams are usually chosen there.
Yes, and you should — at a different time of day, so you are not diluting the steroid or spreading it beyond the rash.
The steroid treated the inflammation, not the cause. Expected in eczema and psoriasis, and why maintenance and steady moisturizing matter.
Yes. It was developed for once-daily use and the trials were done that way. Twice a day adds side effect risk without benefit.
A short sting on broken skin is common and settles. Burning that builds over days, or a worsening rash, can mean infection or a reaction to the base.
A large protein grown in living cells rather than a chemical made in a factory. That is why it is injected, and why it lives in the fridge.
After the first two doses, four weeks apart, yes. The drug stays in the body long enough that the gap can be twelve weeks.
A few seconds of stinging. Letting it warm to room temperature first makes a noticeable difference.
Tuberculosis and hepatitis before you start, and TB testing often repeated yearly. Beyond that, no routine schedule.
Inject when you remember and count twelve weeks from that day. If you are weeks or months late, call first.
Yes, apart from live ones. The flu shot, COVID vaccines and Shingrix are not live. Have any live ones before starting.